pharmaphorum

FEBRUARY 3, 2022

India’s Dr Reddy’s Laboratories has joined the growing list of pharma companies that are looking to tap into the market for medical cannabis, buying German developer Nimbus Health for an undisclosed sum. The two drugs were developed by medical cannabis pioneer GW Pharma, which was acquired by Jazz last year.

Licensing 119

Licensing Licensing Marketing Medicine 119

Pharmaceutical Technology

SEPTEMBER 2, 2022

In a recent report, GlobalData revealed that the US Food and Drug Administration (FDA) approved 122 new drug applications (NDAs) and biologic license applications (BLAs) in 2021. This is where partners such as Abacus Medicine Pharma Services can really help,” says Simon Estcourt, managing director of Abacus Medicine Pharma Services.

Drugs 130

Drugs Pharma Companies Medicine Production 130

pharmaphorum

MAY 20, 2022

Several of the top pharmaceutical companies have joined a new coalition that aims to improve access to cancer medicines in low- and lower-middle-income countries (LLMICs). It is taking a broader approach, making sure patients living with cancer “receive the medicines they need at the right time,” he said.

Drugs 111

Drugs Medicine Licensing Licensing 111

pharmaphorum

OCTOBER 28, 2020

Claus Møldrup explores research showing that patients want their voice to be heard more by pharma, and asks what a truly effective feedback loop for medicines might look like. Pharma remains stubbornly closed to feedback, with potentially damaging consequences for the industry, healthcare systems and patients.

Medicine 119

Medicine Pharma Companies Vaccination Vaccine 119

pharmaphorum

MAY 4, 2022

As the technology advances further, it could become possible to harness a patient’s stem cells to create a personalised organ-on-a-chip, offering further potential to create a specific treatment for an individual – the definition of a personalised medicine. Nascent technology.

Drugs 143

Drugs Licensing Licensing Pharma Companies 143

XTalks

MAY 29, 2024

The top ten pharma companies in 2023 by revenue accounted for about 35 percent of the market value, with total earnings of $559.5 The top big pharma players have remained relatively consistent in their market positions over the past several years. Here is a look at the top ten pharma companies in 2024 based on 2023 revenue.

Pharma Companies 52

Pharma Companies Sales FDA Approval Vaccination 52

pharmaphorum

FEBRUARY 11, 2022

Ipsen has started exclusive negotiations that could see its global consumer health business sold to fellow French pharma company Mayoly Spindler later this year. billion takeover of Clementia Pharma in 2019. billion of its revenues last year.

Sales 103

Sales Pharma Companies Branding Cosmetics 103

pharmaphorum

JULY 14, 2022

The legacy product now lies outside Bayer’s core areas of cardiology, oncology, haematology, ophthalmology, women’s health and radiopharmaceuticals, and the funds raised from the sale will support the “ongoing transformation of Bayer’s pharma business to focus on key areas of future medical innovation”, said the company.

Drugs 97

Drugs Sales Pharma Companies Cardiology 97

pharmaphorum

NOVEMBER 29, 2021

It was billed at the time as a key tool to accelerate the development of new and innovative vaccines to combat some of the world’s most prevalent diseases, from discovery to licensed product.

Vaccination 105

Vaccination Vaccine Manufacturing Pharma Companies 105

pharmaphorum

JANUARY 7, 2022

If the last couple of days is an indication, 2022 is already shaping up to be the year of big-ticket alliances between big pharma companies and specialists in artificial intelligence-driven discovery. Shortly after Amgen unveiled its $1.9

Drugs 110

Drugs Pharma Companies Medicine Licensing 110

pharmaphorum

FEBRUARY 13, 2022

If all goes to plan, Merck has the option to obtain up to a five-year exclusive license to use of BioAI in a specific disease domain, which would result in an undisclosed payment to the Israeli startup. “If successful, this could lead to a much-needed transformation in drug development speed, safety and cost,” said Ciechanover.

Drugs 98

Drugs In-Vivo In-Vitro Pharma Companies 98

pharmaphorum

FEBRUARY 12, 2021

This important transaction will further position Sandoz as a global leader in antibiotics – truly essential medicines that are the backbone of modern healthcare systems,” said the company’s chief executive Richard Saynor.

Drugs 111

Drugs Sales Marketing Pharma Companies 111

pharmaphorum

MARCH 26, 2021

The UK Government and EU Commission trumpeted their Brexit trade deal, struck at the end of December, as ‘comprehensive’, the ‘biggest yet’ But a closer inspection of the EU-UK Trade and Cooperation Agreement (TCA) renders these statements largely illusory for the pharma sector. Medical devices do not feature at all.

Production 119

Production Medicine Marketing Regulation 119

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

pharmaphorum

DECEMBER 21, 2020

Compared with many of the established names in pharma these companies are young upstarts but they have managed to achieve what other big names in the industry have failed to do and harness the power of mRNA to make medicine. This will revolutionise medicine over the next 10-15 years in areas we do not even imagine.”.

Vaccination 111

Vaccination Vaccine Doctor Doctors 111

pharmaphorum

JUNE 4, 2021

The technology behind the drug was licensed from Weill Cornell Medicine and Johns Hopkins University in the US. ” The deal – financial terms of which were not disclosed – comes against a backdrop of increasing interest in radionuclide drugs among pharma companies.

Antibody 81

Antibody Licensing Licensing Protein 81

pharmaphorum

OCTOBER 7, 2021

The factory will be able to supply up to 500 million doses of mRNA shots a year, and cover the full spectrum of manufacturing from drug substance production through to full/finish and packaging, according to the company. According to the latest WHO data, just 4.4%

Vaccination 98

Vaccination Vaccine Manufacturing Packaging 98

BioTech 365

OCTOBER 15, 2020

ISTANBUL–(BUSINESS WIRE)– Company name: Er-Kim Ilac Presentative: Cem Zorlular, CEO AnGes, Inc.,

Pharma Companies 40

Pharma Companies Licensing Licensing Gene 40

Camargo

SEPTEMBER 23, 2020

The amount of interest and investment in rare diseases and orphan drugs has grown tremendously in recent years, leading to continuous innovation in a space that was once largely overlooked.

Business Development 136

Business Development Drugs Development Production 136

pharmaphorum

JUNE 11, 2021

Ocugen is the first company to be affected by the FDA’s recent decision to raise the bar on emergency use authorisations for COVID-19 medicines, and will have to file for full approval of its vaccine candidate. Bharat has also reported data suggesting the shot is effective against the beta (B.1.351) 1.351) variant.

Vaccination 83

Vaccination Vaccine Clinical Trials Clinical Trials 83

pharmaphorum

JANUARY 8, 2021

There’s a new player in the neurology and mental health drugs market after Italy’s Angelini Pharma merged with Switzerland’s Arvelle Therapeutics in a deal worth up to $960 million based around the anti-seizure drug cenobamate. Revenue share payments due to certain of the Arvelle shareholders will be assumed by Angelini Pharma.

Licensing 52

Licensing Licensing Pharma Companies Medicine 52

pharmaphorum

NOVEMBER 30, 2022

The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine? The biggest gathering of pharma companies in Europe right now on the commercial side, the Veeva Systems Summit permits the sharing of best practices and of new ideas.

Life Science 98

Life Science Pharma Companies Sales Marketing 98

pharmaphorum

APRIL 22, 2021

Although the company has no agreements in place to acquire any companies, or license in any drugs, Centessa is interested in exploring such opportunities if they arise. The company has an “asset focused” R&D philosophy , where development is centred on the needs of each individual biotech.

Licensing 64

Licensing Licensing Pharma Companies Drugs 64

pharmaphorum

DECEMBER 7, 2020

Having worked all around the world to supply medicines to developing markets, Dr Zulf Masters understands the biggest barrier for a pharma company entering these regions is a lack of understanding of their complexities. The post Latin America: How pharma can navigate a complex market appeared first on.

Marketing 109

Marketing Regulation Production Medicine 109

Delveinsight

AUGUST 2, 2020

Helsinn Group , a Swiss pharma player, is evaluating Anamorelin, an orally active selective ghrelin receptor agonist against Cancer cachexia, The company is conducting Phase III trial to test the efficacy and safety of anamorelin for the treatment of weight loss and anorexia in patients with advanced NSCLC with cachexia.

Marketing 94

Marketing Pharma Companies Development Hormones 94

XTalks

AUGUST 21, 2023

“The FDA approval of Sohonos is a breakthrough for the US FOP community,” said Howard Mayer, head of R&D at Ipsen, in the company’s news release. Development of medicines for rare diseases takes commitment and belief from everyone involved.

Drugs 98

Drugs FDA Approval Genetics Clinical Trials 98

pharmaphorum

MAY 27, 2022

This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. There is a huge opportunity for pharma companies to capitalise on by focusing on increased DEI in clinical trials. What comes next? About the interviewees.

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

pharmaphorum

JANUARY 12, 2021

While there are RNAi products on the marketplace, with Alnylam becoming the first company to get a product approved in 2018, it is difficult to get this class of drug distributed through the brain and spinal cord.

RNA 95

RNA Production Development Pharma Companies 95

pharmaphorum

JANUARY 24, 2023

The collaboration takes CytoReason’s partnering with leading pharmaceutical companies to a total of five. Through use of precision medicine and machine learning (ML), the company’s cell-centred models will aid identification of patient subtypes and pair them with personalised IBD targets. Image source: Kindel Media on Pexels.

Medicine 52

Medicine Drugs Pharma Companies Clinical Trials 52

Delveinsight

AUGUST 23, 2021

The therapy has already won Breakthrough therapy designation, and earlier this year the drug became the first treatment to receive an “Innovation Passport” through the Medicines and Healthcare products Regulatory Agency’s (MHRA) new Innovative Licensing and Access Pathway (ILAP).

Marketing 98

Marketing Clinical Trials Clinical Trials Trials 98

pharmaphorum

MAY 13, 2022

According to BridgeBio and other SHP2 developers like Revolution Medicines, Jacobio, Erasca, Redx Pharma and Relay Therapeutics, the phosphatase enzyme – once considered “undruggable” – is over-expressed in a number of different solid tumour types.

Drugs 59

Drugs Pharma Companies Medicine Licensing 59

pharmaphorum

SEPTEMBER 29, 2020

Within the last two decades, large pharmaceutical corporations have established themselves firmly in oncology by prioritising internal R&D efforts, as well as developing and accessing novel science and technology through collaborations and alliances with biotech companies and academic institutions.

Research 132

Research Gene Editing Development Gene 132

XTalks

DECEMBER 13, 2023

Now, let’s delve into the list of the top ten fastest growing biotech companies in 2023, ranked by their compound annual growth rate (CAGR). These companies were identified through The Americas’ Fastest-Growing Companies 2023 list by the Financial Times.

Genetics 111

Genetics Vaccination Vaccine DNA 111

pharmaphorum

DECEMBER 16, 2022

She continued to say that the stockpiling of vaccines and treatments in richer nations had left other nations without access to lifesaving medicine. This could mean that the pharma companies would need to disclose pricing and contractual terms for pandemic products, as well as mechanisms to transfer technology and expertise.

Vaccination 96

Vaccination Vaccine Production Licensing 96

pharmaphorum

DECEMBER 9, 2022

Sanofi has walked away from a four-year-old partnership with Revolution Medicines focused on an SHP2 inhibitor, intended as a combination with KRAS inhibitors, including Sanofi’s Mirati-partnered adagrasib.

Pharma Companies 59

Pharma Companies Licensing Licensing Trials 59

Fossil Remedies

NOVEMBER 22, 2022

You can become part of a big company network as a PCD pharma distributor or a PCD pharma firm. Other than conventional medicines, nowadays, people are making good money by opening franchises in Neuro products, Ayurvedic medicines, Gynec products, etc. Wide range of products. Pricing strategy.

Pharma Production 52

Pharma Production Branding Production Marketing 52

pharmaphorum

NOVEMBER 12, 2020

The mid-sized pharma group has also signed a collaboration with Florida, US-based Lacerta Therapeutics , adding more AAV capsids – well established as a staple for delivering gene therapy sequences – as well as another gene therapy candidate.

Gene Therapy 52

Gene Therapy Gene Manufacturing Contract Manufacturing 52